Urteste S.A. (WSE:URT)

Poland flag Poland · Delayed Price · Currency is PLN
46.00
+0.20 (0.44%)
Jul 4, 2025, 3:51 PM CET
-45.11%
Market Cap 64.84M
Revenue (ttm) 1.54M
Net Income (ttm) -3.04M
Shares Out 1.41M
EPS (ttm) -2.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 393
Average Volume 765
Open 46.00
Previous Close 45.80
Day's Range 45.00 - 46.00
52-Week Range 45.00 - 107.00
Beta -0.06
RSI 26.46
Earnings Date Aug 27, 2025

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

In 2024, Urteste's revenue was 1.80 million, an increase of 35.34% compared to the previous year's 1.33 million. Losses were -3.63 million, -35.00% less than in 2023.

Financial Statements

News

There is no news available yet.